Phil Reason, chief executive of Instem Plc (LON:INS), tells Proactive's Andrew Scott they've been awarded a new two-year SEND (Standard for the Exchange of Nonclinical Data) outsourced services contract.
The contract has been awarded by an unnamed top five global nonclinical contract research organisation (CRO) and is worth in excess of ?1.7mln over an initial two-year period.
Meet Netscientific PLC, discoverIE Group plc, Itaconix Plc and Realm Therapeutics plc at our event, London, 25 January 2018.Register here >>